Clinical Trials Logo

Clinical Trial Summary

This study aims to provide psychological support to women that experienced an Early Pregnancy Loss (when the loss occurs until the 20 weeks of gestation) using an innovative Virtual Reality prototype and compare the presence and evolution of psychological distress symptoms pre and post-intervention. The main goals of this study are: 1. Evaluate the impact of the proposed VR paradigm in women who suffered a gestational loss in the first 20 weeks of gestation, compared to a control group that follows the usual standard care; 2. Evaluate the usability, user experience, and acceptance of the proposed approach. Participants in the VR group will have an intervention program lasting four weeks, with 3 weekly sessions of 45-60 minutes, using the developed prototype.


Clinical Trial Description

Early pregnancy loss occurs in about 20% of all pregnancies and can lead to chronic grief and psychological distress symptomatology. Although the high prevalence, it is still a very undervalued event, and proper follow-up and psychological guidance are often absent. The present research study aims to evaluate the feasibility of a psychological VR-based approach in a controlled pilot study with 20 women who suffered an early gestational loss in the last 6 months. Using the developed prototype, the experimental VR group will have an intervention program lasting four weeks, with 3 weekly sessions of 45-60 minutes. The investigators aimed to verify if the use of the proposed VR paradigm will significantly reduce symptoms of grief, depression, anxiety and post-traumatic stress, and that this reduction will be significantly greater compared to the control group. The study proposed is very innovative in terms of the target population and the use of VR, specifically designed to address gestational loss. In addition, it opens a new avenue of research on a topic that is still silenced and considered taboo in society. Thus, this interdisciplinary research has an expected scientific, technological, and social impact, namely: 1) contributes to a better understanding of the process of psychological recovery after an early gestational loss; 2) contributes to the advancement of technologies aimed at psychological support; 3) has the potential to accelerate the resolution of grief by bringing emotional and psychological support to women who do not have access to other means of support; and 4) contributes to reducing the economic burden on health care by providing tools to improve the well-being of patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05880381
Study type Interventional
Source Universidade da Madeira
Contact Mónica Cameirão, PhD
Phone (+351) 291705291
Email monica.cameirao@staff.uma.pt
Status Recruiting
Phase N/A
Start date May 1, 2023
Completion date July 31, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04595760 - Factors Influencing Fertility or Pregnancy Health
Completed NCT01132924 - A Follow-up of the Early Pregnancy Study Cohort.
Terminated NCT04935138 - Cell-free DNA Analysis of Chromosome Anomalies in Early Pregnancy Loss
Completed NCT04410029 - Evaluation of a Decision Aid for Early Pregnancy Loss N/A
Not yet recruiting NCT06452719 - Letrozole and Misoprostol for Early Pregnancy Loss Management: A Prospective Pilot Cohort Study Phase 2
Recruiting NCT04738370 - Assessment of Biomarkers in Pregnancy on Unknown Location and Ectopic Pregnancy
Not yet recruiting NCT06309927 - Operative Hysteroscopy Versus Suction Curettage for Surgical Termination of Early Pregnancy Loss (Miscarriage) N/A